on Rentschler Biopharma SE
Rentschler Biopharma Expands Services in Japan and South Korea
Rentschler Biopharma SE, a renowned global CDMO for biopharmaceuticals, is strengthening its presence in Japan and South Korea. The company plans to present its services at the BioProcess International Asia conference in Kyoto, Japan, from October 20-22, 2025. This event marks a strategic move to engage with existing and potential partners and to adapt its services to local needs.
The company emphasizes its Rentschler Expression Platform, aimed at boosting timelines in Cell Line Development. With long-standing operations in the region, supported by Summit Pharmaceuticals International, Rentschler aims to deepen partnerships and explore new ones.
CEO Benedikt von Braunmühl stated the company's commitment to fast and efficient delivery of high-quality treatments. Through innovative development and manufacturing, Rentschler Biopharma seeks to accelerate medicine delivery worldwide.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Rentschler Biopharma SE news